| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |